Counseling Points - September 2007 - (Page 18)

Counseling Points™ Office-based Medication-assisted Treatment of Opioid Dependence Continuing Education Posttest To receive credit, please read the newsletter in its entirety, answer the posttest and evaluation questions on page 19, and mail or fax the form to: Delaware Media Group, 66 South Maple Ave., Ridgewood, NJ 07450, Fax (201) 612-8282. (If you are completing the posttest online, simply hit the “submit” button.) Certificates from the Wisconsin Nurses Association and the Pennsylvania Certification Board (if you check the box applying for substance abuse credits) will be awarded for a score of 80% (10 correct) or better. Certificates will be mailed within 4-6 weeks. There is no charge for these credits. 1. SAMHSA-funded studies in 2005 estimate there may be as many as million Americans classified as having a substance abuse or dependence problem. A. 2.3 million B. 12 million C. 22.5 million D. 52 million 2. Features that should be considered red flags for potential opioid dependence or misuse are: A. poor nutritional status B. poor personal hygiene C. signs of physical abuse D. all of the above 3. CAGE-AID is a: A. questionnaire for identifying people at risk of opioid dependency B. medication used to prevent opioid withdrawal C. physical restraint used for in-patient treatment D. measurement of binding affinity 4. The degree to which a drug stimulates an opioid receptor is called: A. binding affinity B. receptor confluence C. receptor attachment D. intrinsic activity 5. The potential for fatal overdose from an opioid agent results from the effects of: A. gastric motility B. respiratory depression C. euphoria D. analgesia 6. Precipitated withdrawal is a condition that: A. is associated with decreased dosing of any opioid B. is much milder than spontaneous withdrawal C. is deliberately induced D. occurs when a patient has taken a full mu agonist prior to buprenorphine induction 7. Buprenorphine is an agent that is: A. a full opioid agonist B. a partial opioid agonist C. an opioid antagonist D. a popular recreational drug 8. Which of the following is NOT a goal of induction? A. Preventing precipitated withdrawal B. Stabilizing the patient for maintenance therapy C. Providing important counseling D. Preparing the patient for referral 9. The law currently allows a physician who has been certified for 1 year to treat how many patients with buprenorphine? A. 18 B. 30 C. 100 D. 200 10. To begin induction of buprenorphine treatment, an opioid-dependent patient needs to be: A. verified as experiencing opioid withdrawal B. prepared for severe withdrawal symptoms C. drug-free for a minimum of 36 hours D. pretreated with methadone 11. During induction with buprenorphine, the patient should return for titration to a stabilizing dose. Most patients stabilize at a dose of: A. 2-4 mg B. 8 mg C. 12-16 mg D. 20-24 mg 12. Buprenorphine alone produces: A. respiratory depression that has a ceiling effect B. cannot produce overdose effects C. needs to be given in higher doses D. needs to be taken at least twice daily 18 COUNSELING POINTS™

Table of Contents Feed for the Digital Edition of Counseling Points - September 2007

Welcome Office-Based Medication-Assisted Treatment of Opioid Dependence Summary Continuing Education Posttest Postest Answer and Program Evaluation Form

Counseling Points - September 2007

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.